Filana Therapeutics, Inc. (FLNA) vs Precipio, Inc. (PRPO)
A side-by-side comparison of Filana Therapeutics, Inc. and Precipio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FLNA
Filana Therapeutics, Inc.
$0.85HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
PRPO
Precipio, Inc.
$23.62HealthcareDelayed quote: Oct 6, 2026, 2:52 PM EDT
Total return — FLNA vs PRPO
growth of $100 · dividends reinvested · last 1yFLNA -57.6% (-57.6%/yr)PRPO +13.4% (+13.4%/yr)PRPO compounded faster over this window
FLNA PRPO
FLNA vs PRPO: by the numbers
- •PRPO is the larger company ($42M vs $41M market cap).
- •Both run net losses; FLNA's is the smaller (0.00% vs -4.42% net margin).
Metrics side by side
Valuation
| Metric | FLNA | PRPO |
|---|---|---|
| P/S ratio | N/A | 1.53 |
| P/B ratio | 0.64 | 2.85 |
| FCF yield | N/A | 1.87% |
Profitability
| Metric | FLNA | PRPO |
|---|---|---|
| Gross margin | 0.00% | 43.69% |
| Operating margin | 0.00% | -5.63% |
| Net margin | 0.00% | -4.42% |
| ROE | -66.47% | -8.23% |
| ROIC | -72.12% | -8.43% |
Growth (annualized)
| Metric | FLNA | PRPO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 28.84% |
| Total return CAGR (5Y) | N/A | -14.46% |
Go deeper
Dig into the metrics
Filana Therapeutics ROEPrecipio ROEFilana Therapeutics operating marginPrecipio operating marginFilana Therapeutics revenue growthPrecipio revenue growthFilana Therapeutics free cash flowPrecipio free cash flow
Filana Therapeutics & Precipio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.